MedPath

A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

Not yet recruiting
Conditions
Gynecologic Disease
Intestines Cancer
Liver Cancer
Trauma
Fractures, Bone
Pulmonary Cancer
Registration Number
NCT05781581
Lead Sponsor
RenJi Hospital
Brief Summary

To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50000
Inclusion Criteria
  • Age≥18 years;
  • Patients undergoing any type of surgery in operating room.
Exclusion Criteria
  • Surgery under local anesthesia (without participation of anesthetist)
  • Surgery outside the operating room, such as gastrointestinal endoscopy, puncture biopsy, etc
  • Patients who cannot determine whether they have had SARS CoV-2 infection before surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause mortality at 30 days after operation30 days after surgery

All-cause mortality at 30 days after operation

Secondary Outcome Measures
NameTimeMethod
Main pulmonary complications at 30 days after operation30 days after surgery

a composite of postoperative pneumonia, acute respiratory distress syndrome (ARDS) and unexpected ventilation

Major Adverse Cardiovascular Events (MACE)30 days after surgery

a composite of cardiogenic death, myocardial infarction, new-onset heart failure or cardiogenic shock, and cerebrovascular accident (CVA)

© Copyright 2025. All Rights Reserved by MedPath